Portugal INFARMED

Quadrixam (Perindopril + Indapamida + Amlodipina + Bisoprolol) – Withdrawal of public reimbursement request

Original title: Quadrixam (Perindopril + Indapamida + Amlodipina + Bisoprolol) | Relatório de avaliação de financiamento público disponível na Infomed | Desistência do pedido de comparticipação

Applicant withdrew request for public reimbursement funding of Quadrixam combination antihypertensive medicine.

Low obligation Product class Pharmaceuticals Portugal Pharmaceuticals

SubscreverSubscrever Notícias

Read the official source ↗

Published by Portugal INFARMED. HealthSignal links to the original document; the summary above is extracted from the source text.